The Administrative Core is led by Center Director Ramnik Xavier and Associate Directors Atul Bhan, Cornelis Terhorst, and Mark Daly. The activities of the Center?s Administrative Core serve to support the Center?s goals of promoting interactions among scientists exploring diverse fields which share relevance to IBD, attracting investigators to the study of IBD, and providing an environment and mechanism to foster development of young investigators focused on IBD. We believe all these goals are achieved through the scientific and material resources provided via the organizational framework of this Center.
The specific aims of the Administrative Core are to (1) promote scientific interactions among members; (2) coordinate the Enrichment Program offerings; (3) facilitate and provide oversight of the Pilot and Feasibility Program; (4) identify, help develop, and promote tools, technologies, and collaborations; (5) assist the director in making general, administrative, and scientific decisions concerning the overall direction of the CSIBD and plans to implement changes and/or new initiatives within the Center and provide ongoing assessment of productivity, effectiveness, and appropriateness of biomedical core activities; and (6) facilitate interactions with other DDRCCs, the NIDDK and other appropriate individuals, groups, and/or organizations and maintain communication of activities through venues such as the CSIBD website. The Administrative Core also manages the collaborative program between the CSIBD and the Broad Institute, which has been expanded in the current funding period to include ?Core Enhancement? grants that enable access to Broad Institute-based platforms. More details on this program are provided in the Administrative Core Research Strategy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK043351-26
Application #
8972389
Study Section
Special Emphasis Panel (ZDK1)
Project Start
1997-01-01
Project End
2020-12-31
Budget Start
2016-03-15
Budget End
2016-12-31
Support Year
26
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
Qu, Chen; Zheng, Dandan; Li, Sai et al. (2018) Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis. Hepatology :
Simon, Tracey G; King, Lindsay Y; Chong, Dawn Q et al. (2018) Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. Hepatology 67:1797-1806
Borren, Nienke Z; Conway, Grace; Garber, John J et al. (2018) Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases. J Crohns Colitis 12:525-531
Battistone, Maria A; Nair, Anil V; Barton, Claire R et al. (2018) Extracellular Adenosine Stimulates Vacuolar ATPase-Dependent Proton Secretion in Medullary Intercalated Cells. J Am Soc Nephrol 29:545-556
Imhann, Floris; Vich Vila, Arnau; Bonder, Marc Jan et al. (2018) Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut 67:108-119
Chandradas, Sajiv; Khalili, Hamed; Ananthakrishnan, Ashwin et al. (2018) Does Obesity Influence the Risk of Clostridium difficile Infection Among Patients with Ulcerative Colitis? Dig Dis Sci 63:2445-2450
Luther, Jay; Gala, Manish; Patel, Suraj J et al. (2018) Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways. Dig Dis Sci 63:738-745
Graham, Daniel B; Luo, Chengwei; O'Connell, Daniel J et al. (2018) Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes. Nat Med 24:1762-1772
Schirmer, Melanie; Franzosa, Eric A; Lloyd-Price, Jason et al. (2018) Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat Microbiol 3:337-346
Cheung, Pui W; Terlouw, Abby; Janssen, Sam Antoon et al. (2018) Inhibition of non-receptor tyrosine kinase Src induces phosphoserine 256-independent aquaporin-2 membrane accumulation. J Physiol :

Showing the most recent 10 out of 1166 publications